LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Search

ResMed Inc

Închisă

SectorSănătate

252 0.44

Rezumat

Modificarea prețului

24h

Curent

Minim

249.71

Maxim

252.76

Indicatori cheie

By Trading Economics

Venit

44M

393M

Vânzări

87M

1.4B

P/E

Medie Sector

25.005

110.024

Randament dividend

0.92

Marjă de profit

27.593

Angajați

10,600

EBITDA

63M

566M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+15.28% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.92%

2.26%

Următoarele câștiguri

22 apr. 2026

Data viitoare de dividende

19 mar. 2026

Următoarea dată ex-dividende

7 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-426M

37B

Deschiderea anterioară

251.56

Închiderea anterioară

252

Sentimentul știrilor

By Acuity

17%

83%

23 / 351 Clasament în Healthcare

ResMed Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 feb. 2026, 23:07 UTC

Câștiguri

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb. 2026, 23:01 UTC

Câștiguri

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb. 2026, 22:59 UTC

Câștiguri

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 feb. 2026, 22:42 UTC

Câștiguri

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 feb. 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 feb. 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 feb. 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 feb. 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 feb. 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 feb. 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24 feb. 2026, 23:16 UTC

Câștiguri

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 feb. 2026, 23:13 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 feb. 2026, 23:12 UTC

Câștiguri

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 feb. 2026, 23:10 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 feb. 2026, 23:10 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 feb. 2026, 23:08 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 feb. 2026, 23:07 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 feb. 2026, 22:52 UTC

Câștiguri

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb. 2026, 22:46 UTC

Câștiguri

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb. 2026, 22:31 UTC

Achiziții, Fuziuni, Preluări

Warner Receives New Bid From Paramount -- 3rd Update

24 feb. 2026, 22:29 UTC

Câștiguri

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 feb. 2026, 22:28 UTC

Câștiguri

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 feb. 2026, 22:27 UTC

Câștiguri

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 feb. 2026, 22:27 UTC

Câștiguri

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 feb. 2026, 22:25 UTC

Câștiguri

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 feb. 2026, 22:24 UTC

Câștiguri

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 feb. 2026, 22:23 UTC

Câștiguri

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 feb. 2026, 22:22 UTC

Câștiguri

Woolworths Interim Dividend 45 Australian Cents/Share

24 feb. 2026, 22:22 UTC

Câștiguri

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 feb. 2026, 22:21 UTC

Câștiguri

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Comparație

Modificare preț

ResMed Inc Așteptări

Obiectiv de preț

By TipRanks

15.28% sus

Prognoză pe 12 luni

Medie 300.64 USD  15.28%

Maxim 345 USD

Minim 265 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruResMed Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

8

Cumpărare

5

Păstrare

0

Vânzare

Sentiment

By Acuity

23 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat